表紙
市場調查報告書

內皮層功能障礙:全球臨床實驗檢討

Endothelial Dysfunction Global Clinical Trials Review, H2, 2019

出版商 GlobalData 商品編碼 312392
出版日期 內容資訊 英文
訂單完成後即時交付
價格
Back to Top
內皮層功能障礙:全球臨床實驗檢討 Endothelial Dysfunction Global Clinical Trials Review, H2, 2019
出版日期: 2019年12月15日內容資訊: 英文
簡介

本報告提供內皮層功能障礙的治療藥相關臨床實驗調查分析,提供您最新趨勢,各階段及Phase狀況,有潛力的企業,開發中的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:心血管系統臨床實驗上內皮層功能障礙的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:心血管系統臨床實驗上內皮層功能障礙的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

各類贊助商臨床實驗

有潛力的贊助商

  • 內皮層功能障礙治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • BioMarin Pharmaceutical Inc.
    • 武田藥品工業
    • Sanofi
    • Nestle S.A.
    • Gilead Sciences, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Defense Medical College
    • Mayo Clinic
    • Radboud University
    • Boston University
    • Gulhane School of Medicine
    • 岡山大學大學院醫生牙齒藥學綜合研究科
    • Vanderbilt University
    • University of Dundee
    • Emory University
    • UMC Utrecht Holding BV

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC6011CTIDB

GlobalData's clinical trial report, "Endothelial Dysfunction Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Endothelial Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Endothelial Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Endothelial Dysfunction Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region, 2019*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*
  • Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, G7 Countries (%), 2019*
  • Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Endothelial Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials, E7 Countries (%), 2019*
  • Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Endothelial Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Endothelial Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Endothelial Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Endothelial Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Endothelial Dysfunction Therapeutics, Global, C
Back to Top